Article
Persistence of HIV-1 drug resistance mutations and emergence during antiretroviral treatment interruption: considerations from a clinical case.
Medical science monitor : international medical journal of experimental and clinical research - 1 Apr 2003
Torti Carlo, Moretti Francesca, Uccelli Maria C, Tirelli Valeria, Quiros-Roldan Eugenia, Gargiulo Franco, Carosi Giampiero
Abstract excerpt
BACKGROUND: HIV drug resistance (HDR) represents a crucial problem in antiretroviral therapy today. HDR mutations can accumulate, persist in the proviral genome and re-emerge, promoting further failure of rescue regimens. Resistance testing on the proviral genome has been suggested in order to detect the presence of archived resistance mutations and to guide drug prescription. CASE REPORT: We report the...
Topics
- Anti-HIV Agents
- Antiretroviral Therapy, Highly Active
- DNA, Viral
- Drug Administration Schedule
- Drug Resistance, Multiple, Viral
- Drug Resistance, Viral
- Drug Therapy, Combination
- Female
- Genotype
